PARP inhibitory v léčbě karcinomu prsu u pacientek s BRCA mutací

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English PARP inhibitors in the treatment of breast cancer patients with BRCA mutations
Authors

HALÁMKOVÁ Jana PETRÁKOVÁ Katarína KISS Igor

Year of publication 2014
Type Article in Proceedings
Conference Onkologická revue
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords hereditary breast cancer; BRCA1; BRCA2; PARP inhibitors
Description Breast cancer is one of the most common malignant tumors in women, about 10 % of these tumours are represented by hereditary breast cancer, mainly due to mutations in BRCA1 a BRCA2 geenes.

You are running an old browser version. We recommend updating your browser to its latest version.

More info